Advanced search

Search results      


The Role of Osteopathic Manipulative Treatment in the Treatment of Fibromyalgia Syndrome

Journal: The Journal of the American Osteopathic Association Date: 2006/08, 106(8):Pages: 472. doi: Subito , type of study: clinical trial

Full text    (https://www.degruyter.com/document/doi/10.7556/jaoa.2006.106.8.471/html)

Keywords:

clinical trial [627]
cranio-sacral osteopathy [184]
fibromyalgia [34]

Abstract:

Hypotheses: Adding Osteopathic Manipulative Treatment (OMT) to the treatment of Fibromyalgia Syndrome (FMS) would: decrease the effect FMS had on the patient's activity shown by a decreasing Fibromyalgia Impact Questionnaire (FIQ) score; decrease the amount of symptoms and syndromes the patient experienced shown by a decreasing Symptoms and Associated Syndromes Questionnaire (SASQ) score; decrease the amount of time it would take the patient to walk 75 feet; and decrease the amount of pain medication the patient required. Materials and Methods: Nine possible subjects were recruited. Of these nine, five were enrolled. Of the five enrolled subjects, four completed the protocol. One subject dropped out for personal reasons. Each subject was evaluated and treated for 8 weeks. Each week, the patient filled out the FIQ and the SASQ and recorded their medication use in a diary. On weeks one and eight, the amount of time it took the subject to walk 75 feet was recorded. Osteopathy in the Cranial Field (OCF) treatment was given weekly. The OMT protocol was designed to address somatic dysfunction in the sphenobasilar synchondrosis, occipital-atlantal and atlantal-axial joints, 2nd cervical vertebrae and sacrum. The clinical endpoint of the model was improved symmetry, amplitude, vitality, and rate of the Cranial Rhythmic Impulse. All findings were recorded. Results: Two of the four subjects had decreases in their FIQ scores from 28 to 14 and from 80 to 23. All four subjects had decreases in their SASQ scores from 29 to 25, from 31 to 29, from 37 to 30, and from 42 to 30. All four subjects also decreased the amount of time it took them to walk 75 feet with the decrease ranging from 1.5s to 10.1s. One subject showed a dramatic decrease in pain medication use going from using 2 medications to not using any medication. The remaining subjects varied in medication use. Conclusion: This study supported the hypotheses, by showing a reduction in all proposed categories, but due to the small number of subjects, statistical significance cannot be properly assessed. The results suggest that OCF may be of benefit for patients with FMS. Expanding this study over a longer period of time, with a larger subject pool will provide definitive answers as to the benefit of OMT in FMS.


Search results      

 
 
 






  • ImpressumLegal noticeDatenschutz


ostlib.de/data_nqckwmazuvjsbfythedr



Supported by

OSTLIB recommends